The RACKED paper describes a planned comparison of intramuscular ketamine with midazolam plus haloperidol; it does not report treatment results.
The protocol proposed approximately 184 participants and a primary outcome of time to adequate behavioral control measured with the Richmond Agitation-Sedation Scale. It specified equal allocation between treatment arms and follow-up safety assessment. These details explain the intended question and how success would be defined.
The supplied article uses prospective language and reports plans, including blinding and enrollment logistics. It supplies no observed difference in speed, adverse events, or treatment failure. It should therefore never be cited as proof that ketamine beat the benzodiazepine-containing regimen, or vice versa. For interpreting later clinical claims, the useful distinction is between a prespecified endpoint and an actual outcome. The combination comparator also would not isolate the independent contribution of midazolam from haloperidol.
Original analysis of the supplied journal article, identified as PMC6258312.